Literature DB >> 21880768

Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression.

Young-Eui Kim1, Jin-Hyoung Lee, Eui Tae Kim, Hye Jin Shin, Su Yeon Gu, Hyang Sook Seol, Paul D Ling, Chan Hee Lee, Jin-Hyun Ahn.   

Abstract

The interferon-inducible Sp100 proteins are thought to play roles in the chromatin pathway and in transcriptional regulation. Sp100A, the smallest isoform, is one of the major components of PML nuclear bodies (NBs) that exhibit intrinsic antiviral activity against several viruses. Since PML NBs are disrupted by the immediate-early 1 (IE1) protein during human cytomegalovirus (HCMV) infection, the modulation of Sp100 protein expression or activity during infection has been suggested. Here, we show that Sp100 proteins are lost largely in the late stages of HCMV infection. This event required viral gene expression and involved posttranscriptional control. The mutant virus with deletion of the sequence for IE1 (CR208) did not have Sp100 loss. In CR208 infection, PML depletion by RNA interference abrogated the accumulation of SUMO-modified Sp100A and of certain high-molecular-weight Sp100 isoforms but did not significantly affect unmodified Sp100A, suggesting that the IE1-induced disruption of PML NBs is not sufficient for the complete loss of Sp100 proteins. Sp100A loss was found to require proteasome activity. Depletion of all Sp100 proteins by RNA silencing enhanced HCMV replication and major IE (MIE) gene expression. Sp100 knockdown enhanced the acetylation level of histones associated with the MIE promoter, demonstrating that the repressive effect of Sp100 proteins may involve, at least in part, the epigenetic control of the MIE promoter. Sp100A was found to interact directly with IE1 through the N-terminal dimerization domain. These findings indicate that the IE1-dependent loss of Sp100 proteins during HCMV infection may represent an important requirement for efficient viral growth.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880768      PMCID: PMC3209270          DOI: 10.1128/JVI.00758-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Sp100 interacts with ETS-1 and stimulates its transcriptional activity.

Authors:  Christine Wasylyk; Sophie E Schlumberger; Paola Criqui-Filipe; Bohdan Wasylyk
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein.

Authors:  Heejung Kang; Eui Tae Kim; Hye-Ra Lee; Jung-Jin Park; Yoon Young Go; Cheol Yong Choi; Jin-Hyun Ahn
Journal:  J Gen Virol       Date:  2006-08       Impact factor: 3.891

3.  Specification of SUMO1- and SUMO2-interacting motifs.

Authors:  Christina-Maria Hecker; Matthias Rabiller; Kaisa Haglund; Peter Bayer; Ivan Dikic
Journal:  J Biol Chem       Date:  2006-03-08       Impact factor: 5.157

4.  Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro.

Authors:  Chris Boutell; Seth Sadis; Roger D Everett
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  SP100 inhibits ETS1 activity in primary endothelial cells.

Authors:  John S Yordy; Omar Moussa; Huiping Pei; Damien Chaussabel; Runzhao Li; Dennis K Watson
Journal:  Oncogene       Date:  2005-01-27       Impact factor: 9.867

6.  Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100.

Authors:  Paul D Ling; Rong Sheng Peng; Ayako Nakajima; Jiang H Yu; Jie Tan; Stephanie M Moses; Wei-Hong Yang; Bo Zhao; Elliott Kieff; Kenneth D Bloch; Donald B Bloch
Journal:  EMBO J       Date:  2005-09-22       Impact factor: 11.598

7.  The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a.

Authors:  Haidong Gu; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-10       Impact factor: 11.205

8.  A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling.

Authors:  Christina Paulus; Steffen Krauss; Michael Nevels
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-23       Impact factor: 11.205

9.  PIAS1 enhances SUMO-1 modification and the transactivation activity of the major immediate-early IE2 protein of human cytomegalovirus.

Authors:  Jang-Mi Lee; Hee-Jung Kang; Hye-Ra Lee; Cheol Yong Choi; Won-Jong Jang; Jin-Hyun Ahn
Journal:  FEBS Lett       Date:  2003-12-04       Impact factor: 4.124

10.  PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0.

Authors:  Roger D Everett; Sabine Rechter; Peer Papior; Nina Tavalai; Thomas Stamminger; Anne Orr
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

View more
  49 in total

1.  Herpesvirus saimiri antagonizes nuclear domain 10-instituted intrinsic immunity via an ORF3-mediated selective degradation of cellular protein Sp100.

Authors:  Florian Full; Nina Reuter; Katrin Zielke; Thomas Stamminger; Armin Ensser
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Viral FGARAT Homolog ORF75 of Rhesus Monkey Rhadinovirus Effects Proteasomal Degradation of the ND10 Components SP100 and PML.

Authors:  Alexander S Hahn; Anna K Großkopf; Doris Jungnickl; Brigitte Scholz; Armin Ensser
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

3.  Sp100A is a tumor suppressor that activates p53-dependent transcription and counteracts E1A/E1B-55K-mediated transformation.

Authors:  J Berscheminski; J Brun; T Speiseder; P Wimmer; W H Ip; M Terzic; T Dobner; S Schreiner
Journal:  Oncogene       Date:  2015-10-19       Impact factor: 9.867

4.  Sp100 isoform-specific regulation of human adenovirus 5 gene expression.

Authors:  Julia Berscheminski; Peter Wimmer; Juliane Brun; Wing Hang Ip; Peter Groitl; Tim Horlacher; Ellis Jaffray; Ron T Hay; Thomas Dobner; Sabrina Schreiner
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

5.  SAMHD1 Modulates Early Steps during Human Cytomegalovirus Infection by Limiting NF-κB Activation.

Authors:  Eui Tae Kim; Kathryn L Roche; Katarzyna Kulej; Lynn A Spruce; Steven H Seeholzer; Donald M Coen; Felipe Diaz-Griffero; Eain A Murphy; Matthew D Weitzman
Journal:  Cell Rep       Date:  2019-07-09       Impact factor: 9.423

6.  Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection.

Authors:  Mandy Glass; Roger D Everett
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

7.  Interferon Kappa Inhibits Human Papillomavirus 31 Transcription by Inducing Sp100 Proteins.

Authors:  Christina Habiger; Günter Jäger; Michael Walter; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

Review 8.  Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape.

Authors:  Santo Landolfo; Marco De Andrea; Valentina Dell'Oste; Francesca Gugliesi
Journal:  World J Virol       Date:  2016-08-12

9.  MORC3, a Component of PML Nuclear Bodies, Has a Role in Restricting Herpes Simplex Virus 1 and Human Cytomegalovirus.

Authors:  Elizabeth Sloan; Anne Orr; Roger D Everett
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 10.  Disruption of host antiviral resistances by gammaherpesvirus tegument proteins with homology to the FGARAT purine biosynthesis enzyme.

Authors:  Kevin Tsai; Troy E Messick; Paul M Lieberman
Journal:  Curr Opin Virol       Date:  2015-08-07       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.